Better Than Bitcoin? (Top Crypto for Less Than $1)

Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.

Popular

Questions emerge about NYC gunman's mental health and his security-sensitive job in Las Vegas

LAS VEGAS (AP) — The man who stormed a Manhattan office tower with a gun, before killing himself, worked in the surveillance department of a Las Vegas casino, part of an industry built on watching for threats before they unfold.

Nebraska congressman Flood gets an earful over Trump's tax cut law in raucous town hall

LINCOLN, Neb. (AP) — Rep. Mike Flood has gotten an earful during a public meeting in Lincoln aimed at discussing his support for the massive that passed Congress and was signed into law by President Donald Trump.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

WASHINGTON (AP) — U.S. health regulators are warning doctors and patients about safety issues with two separate heart devices recently linked to injuries and deaths.

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

Palestinian death toll surpasses 60,000 in the Israel-Hamas war, Gaza’s Health Ministry says

DEIR AL-BALAH, Gaza Strip (AP) — More than 60,000 Palestinians have been killed during the Israel-Hamas war, Gaza’s Health Ministry said Tuesday. Israeli strikes overnight killed more than two dozen people, mostly women and children, according to health officials.

Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study

Alkermes' alixorexton met key endpoints in a Phase 2 trial for narcolepsy type 1, showing strong efficacy and tolerability across all doses.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

France’s top court strikes down pesticide clause in farming law

PARIS (AP) — France’s highest court on Thursday blocked a key part of a contentious farming law that would have brought back a banned pesticide.

Eli Lilly Co. Q2 FY2025 Earnings Transcript

Eli Lilly delivered a strong Q2 2025 with 38% revenue growth and major clinical milestones, despite a selloff over obesity drug trial data.

Trump's Green Light For Stocks? - Ad

Washington just opened tens of millions of federal acres for drilling and mining-a clear sign it's unlocking vast assets. Whitney Tilson says certain companies could be next, with past moves seeing gains up to 4,300%.

Trump once hailed mRNA vaccines as a 'medical miracle.' Now RFK Jr. is halting advancement

WASHINGTON (AP) — President hailed as a “medical miracle” the mRNA vaccines developed to combat the deadly in 2020.

Compounded GLP-1s And Competition Force Novo Nordisk To Slash Outlook

Novo Nordisk reported Q2 sales of $11.7 billion, missing consensus. Sales increased by 13% in Danish kroner, driven by GLP-1 diabetes and obesity care sales.

Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad

Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.

BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030

BioMarin beats Q2 expectations on strong enzyme therapy sales and raises full-year earnings and revenue guidance amid continued Voxzogo growth.

Briumvi's Strong Sales Can't Stop TG Therapeutics Stock Slide

TG Therapeutics missed Q2 earnings and revenue expectations but raised its 2025 Briumvi sales guidance following strong global growth.

Better Than Bitcoin? (Top Crypto for Less Than $1) - Ad

Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.

AMA and other medical associations are kicked out of CDC vaccine workgroups

NEW YORK (AP) — U.S. health officials have told more than a half-dozen of the nation's top medical organizations that they will no longer help establish vaccination recommendations.

Asian shares retreat after Trump's order imposing new tariffs on 68 countries and the EU

MANILA, Philippines (AP) — Asian shares retreated Friday following that saw more losses as investors assess President Donald Trump's order in seven days.

Our No.1 AI Stock Has Nothing to Do With Tech - Ad

Nvidia CEO Jensen Huang recently said AI requires "100 times more" power. We believe that means the best way to invest in AI right now has nothing to do with technology ... And everything to do with energy. One stock appears to be perfectly positioned...

CVS Health hikes 2025 forecast again, boosted by insurance, pharmacy businesses

CVS Health topped Wall Street expectations for the second quarter and hiked its , as the health care giant continued to rally under new management from a forgettable 2024.

Trump administration is launching a new private health tracking system with Big Tech's help

WASHINGTON (AP) — The administration is pushing an initiative for millions of Americans to upload personal health data and medical records on new apps and systems run by private tech companies, promising that will make it easier to access health records and

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Assisted-living facility where fire killed 10 temporarily lost certification for mistreatment

A Massachusetts where a fire killed 10 people earlier this month temporarily lost its certification nearly a decade ago due to resident mistreatment, according to state regulators.

FDA Lifts Safety Hold On Sarepta's Muscular Dystrophy Gene Therapy—Wall Street Cheers

Sarepta stock sees upgrades and price hikes as analysts reassess Elevidys prospects following a favorable FDA development.

The Surprising New Date That Could Fuel the AI Boom - Ad

Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.

Federal judge blocks Arkansas law barring pharmacy benefit managers from owning pharmacies in state

LITTLE ROCK, Ark. (AP) — A federal judge temporarily blocked on Monday Arkansas' first-in-the-nation law that pharmacy benefit managers from owning pharmacies in the state.

Ultragenyx Represents 'Intriguing Buying Opportunity,' Despite Recent Setbacks

HC Wainwright initiates Ultragenyx at Buy with $80 target, citing strong rare disease pipeline and late-stage data expected by year-end.

Weiss Gold Veteran Makes Shocking New Call - Ad

Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.

EU regulator approves injectable HIV drug that experts say could help stop transmission

LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.

Meta launches new teen safety features, removes 635,000 accounts that sexualize children

Instagram parent company Meta has introduced new safety features aimed at protecting teens who use its platforms, including information about accounts that message them and an option to block and report accounts with one tap.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.

Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks

Quest Diagnostics beat Q1 estimates with 15.2% revenue growth and lifted its 2025 guidance amid rising volumes and solid operating margins.

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

FDA names former pharmaceutical company executive to oversee US drug program

WASHINGTON (AP) — The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency’s drug program, the latest in a string of leadership changes at the agency.

Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths

WASHINGTON (AP) — Drugmaker said late Friday it won't comply with a request from the Food and Drug Administration to halt all shipments of receiving one of its treatments for muscular dystrophy.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright technicaltrading.org
Privacy Policy | Terms of Service